Cost-minimization analysis of piperacillin/tazobactam versus imipenem/cilastatin for the treatment of serious infections: a Canadian hospital perspective
Marra, F O, Frighetto, L O, Marra, C A, Sleigh, K M, Stiver, H G, Bryce, E A, Reynolds, R P, Jewesson, P J
Published in The Annals of pharmacotherapy (01.02.1999)
Published in The Annals of pharmacotherapy (01.02.1999)
Get more information
Journal Article